Phase I trial of Exisulind (Aptosyn™) and CPT-11 in patients with colorectal cancer and other solid tumors.

被引：0
|
作者：
Marshall, JL [1 ]
Park, S [1 ]
Al-Sayed, A [1 ]
Fox, E [1 ]
Rizvi, N [1 ]
机构：
[1] Vincent T Lombardi Canc Res Ctr, Washington, DC USA
来源：
CLINICAL CANCER RESEARCH | 2001年 / 7卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
295
引用
收藏
页码：3713S / 3713S
页数：1
相关论文
共 50 条
  • [1] A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer
    Heather Wakelee
    George A. Fisher
    Investigational New Drugs, 2005, 23 : 241 - 242
  • [2] A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer
    Wakelee, H
    Fisher, GA
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (03) : 241 - 242
  • [3] Phase I study of SU5416 in combination with CPT-11 and cisplatin in patients with solid tumors.
    Kraut, EH
    Bender, J
    Clinton, S
    Jensen, R
    Balcerzak, S
    Chan, K
    Mueller, C
    Vaswani, K
    Mantil, J
    Christian, B
    Grever, M
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3661S - 3661S
  • [4] Phase I trial of OSI-774 and CPT-11 in patients with advanced solid tumors
    Rao, RD
    Reid, JM
    Goetz, MP
    Furth, AF
    Mandrekar, SJ
    Adjei, AA
    Ames, MM
    Salgren, SL
    Erlichman, C
    Pitot, HC
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 208S - 208S
  • [5] A phase I study of PHY906 as a modulator of irinotecan (CPT-11) in patients with advanced solid tumors.
    Alsamarai, S.
    Ravage-Mass, L.
    Kaley, K.
    Dutschman, G.
    Zhang, W.
    Jiang, Z.
    Liu, S.
    Cheng, Y. C.
    Chu, E.
    Saif, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] A phase I clinical and pharmacokinetic trial of oxaliplatin and irinotecan (CPT-11) given every two weeks to patients with refractory solid tumors.
    Rothenberg, ML
    McKinney, J
    Hande, KR
    Dorminy, C
    Berlin, H
    Boeing, A
    Johnson, DH
    Purvis, JD
    CLINICAL CANCER RESEARCH, 1999, 5 : 3853S - 3853S
  • [7] PHASE-I STUDY OF CPT-11 AND ETOPOSIDE IN PATIENTS WITH REFRACTORY SOLID TUMORS
    KARATO, A
    SASAKI, Y
    SHINKAI, T
    EGUCHI, K
    TAMURA, T
    OHE, Y
    OSHITA, F
    NISHIO, M
    KUNIKANE, H
    ARIOKA, H
    OHMATSU, H
    NAKASHIMA, H
    SHIRAISHI, J
    SAIJO, N
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) : 2030 - 2035
  • [8] Phase I trial of irinotecan (CPT-11) I in childhood solid tumours
    Pein, F
    Doz, F
    Frappaz, D
    Lucchi, E
    Moretti, S
    Santos, D
    Mignard, D
    Vassal, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1126 - 1126
  • [9] A phase I trial of CPT-11 and S-1 combination chemotherapy in patients with metastatic colorectal cancer
    Yamaguchi, Yoshiyuki
    Minami, Kazuhito
    Kawabuchi, Yoshiharu
    Ohshita, Akiko
    Hironaka, Katsuji
    HEPATO-GASTROENTEROLOGY, 2008, 55 (82-83) : 407 - 411
  • [10] Topoisomerase I expression in tumors as a biological marker for CPT-11 chemosensitivity in patients with colorectal cancer
    Ikeguchi, Masahide
    Arai, Yosuke
    Maeta, Yoshihiko
    Ashida, Keigo
    Katano, Kuniyuki
    Wakatsuki, Toshiro
    SURGERY TODAY, 2011, 41 (09) : 1196 - 1199
12345